{
  "package" : "hl7.fhir.r4.core@4.0.1",
  "definition" : null,
  "system" : "http://terminology.hl7.org/CodeSystem/v2-0227",
  "property" : [ {
    "_uri" : "http://hl7.org/fhir/concept-properties#status",
    "code" : "status",
    "valueCode" : "deprecated"
  }, {
    "_uri" : "http://hl7.org/fhir/concept-properties#deprecationDate",
    "code" : "deprecationDate",
    "valueDateTime" : "2011-01"
  } ],
  "codesystem" : "76219677-b1d6-52c6-bb38-c6d753c0ddc3",
  "concept_id" : "05ad293e-b6ac-5139-9eaf-05c19e0f839c",
  "ancestors" : {
    "TAL" : 0
  },
  "extension" : [ {
    "url" : "http://hl7.org/fhir/StructureDefinition/codesystem-concept-comments",
    "valueString" : "(includes Bayer Biologicals) CDC Changes made on: Feb. 28, 2006",
    "_valueString" : {
      "extension" : [ {
        "url" : "http://hl7.org/fhir/StructureDefinition/translation",
        "extension" : [ {
          "url" : "lang",
          "valueCode" : "nl"
        }, {
          "url" : "content",
          "valueString" : "(inclusief Bayer Biologicals) CDC wijzigingen op: 28 feb 2006"
        } ]
      } ]
    }
  } ],
  "id" : "6c1a73a8-e3c4-4a7f-9fbb-d7e1c13b8d39",
  "code" : "TAL",
  "display" : "Talecris Biotherapeutics",
  "designation" : [ {
    "use" : {
      "code" : "display",
      "system" : "http://terminology.hl7.org/CodeSystem/designation-usage"
    },
    "value" : "Talecris Biotherapeutics",
    "language" : "nl"
  } ],
  "version" : "2.9"
}